US Stock MarketDetailed Quotes
FLGT Fulgent Genetics
- 18.070
- +0.180+1.01%
Close Nov 27 16:00 ET
- 17.800
- -0.270-1.49%
Post 20:01 ET
552.70MMarket Cap-3273P/E (TTM)
18.630High18.020Low155.16KVolume18.030Open17.890Pre Close2.83MTurnover0.76%Turnover RatioLossP/E (Static)30.59MShares30.68052wk High0.49P/B369.06MFloat Cap16.56052wk Low--Dividend TTM20.42MShs Float189.890Historical High--Div YieldTTM3.41%Amplitude2.725Historical Low18.217Avg Price1Lot Size
Fulgent Genetics Stock Forum
Sign in to post a comment
Here’s a financial overview of BxB Main Follow: Paperfolio
1. $NVIDIA (NVDA.US)$ Revenue: For Q3 FY2025, Nvidia reported a record revenue of $35.1 billion, a 94% increase year-over-year. Data Center revenue contributed $30.8 billion, driven by AI adoption.
• Profit: Net income for FY2024 was $29.76 billion, up from $4.37 billion in FY2023, showcasing rapid growth in AI and gaming sectors. Nvidia’s financial statements gov/Archives/ed...
2. $IonQ Inc (IONQ.US)$ Focused on quantum...
1. $NVIDIA (NVDA.US)$ Revenue: For Q3 FY2025, Nvidia reported a record revenue of $35.1 billion, a 94% increase year-over-year. Data Center revenue contributed $30.8 billion, driven by AI adoption.
• Profit: Net income for FY2024 was $29.76 billion, up from $4.37 billion in FY2023, showcasing rapid growth in AI and gaming sectors. Nvidia’s financial statements gov/Archives/ed...
2. $IonQ Inc (IONQ.US)$ Focused on quantum...
3
1
Gainers:
• $Checkmate Pharmaceuticals (CMPI.US)$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics (AXSM.US)$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer (SMCI.US)$ +14.3% (earnings report)
• $Plug Power (PLUG.US)$ +9.24% (t...
• $Checkmate Pharmaceuticals (CMPI.US)$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics (AXSM.US)$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer (SMCI.US)$ +14.3% (earnings report)
• $Plug Power (PLUG.US)$ +9.24% (t...
16
1
Insider selling:
$VIZIO (VZIO.US)$
$Fulgent Genetics (FLGT.US)$
$Cara Therapeutics (CARA.US)$
$KnowBe4 (KNBE.US)$
$Coursera (COUR.US)$
$Intellia Therapeutics (NTLA.US)$
$Natera (NTRA.US)$
$DraftKings (DKNG.US)$
$Natural Alternatives International (NAII.US)$
$Revolve Group (RVLV.US)$
$A10 Networks (ATEN.US)$
$Zuora (ZUO.US)$
Insider Buying
$Spero Therapeutics (SPRO.US)$
$Lumos Pharma (LUMO.US)$
$Oscar Health (OSCR.US)$
$Phibro Animal Health (PAHC.US)$
$VIZIO (VZIO.US)$
$Fulgent Genetics (FLGT.US)$
$Cara Therapeutics (CARA.US)$
$KnowBe4 (KNBE.US)$
$Coursera (COUR.US)$
$Intellia Therapeutics (NTLA.US)$
$Natera (NTRA.US)$
$DraftKings (DKNG.US)$
$Natural Alternatives International (NAII.US)$
$Revolve Group (RVLV.US)$
$A10 Networks (ATEN.US)$
$Zuora (ZUO.US)$
Insider Buying
$Spero Therapeutics (SPRO.US)$
$Lumos Pharma (LUMO.US)$
$Oscar Health (OSCR.US)$
$Phibro Animal Health (PAHC.US)$
24
5
, thank you so much for information
$Fulgent Genetics (FLGT.US)$ any idea why drop so much?
$Fulgent Genetics (FLGT.US)$ Couldn't have been happier here. Who in the hell expects this to happen? Linked the reason why above in blue.
4
24
$Fulgent Genetics (FLGT.US)$ these are the mistakes that over shadow the progress I/We make. I know my style doesn't do well (to this point) when I buy in the most active hours of the market (picket sign reading "No More FOMO" or how about "FOMO YEARS". Yep we're all millionaires with that idea. Somebody print that up on a shirt and send it to me asap. That way we can buy ...
2
10
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Coach Donnie : Let’s GOOO